Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

2769 results about "Cysteine" patented technology

Cysteine (symbol Cys or C; /ˈsɪstiiːn/) is a semiessential proteinogenic amino acid with the formula HO₂CCH(NH₂)CH₂SH. The thiol side chain in cysteine often participates in enzymatic reactions, as a nucleophile. The thiol is susceptible to oxidation to give the disulfide derivative cystine, which serves an important structural role in many proteins. When used as a food additive, it has the E number E920. It is encoded by the codons UGU and UGC.

Pharmaceutical compositions comprising bupropion and cysteine

This disclosure relates to pharmaceutical compositions comprising bupropion and cysteine, and pharmaceutical dosage forms comprising bupropion and cysteine. The disclosure also relates to molecular complexes of bupropion and cysteine. These compositions and dosage forms may have improved stability of bupropion.
Owner:ANTECIP BIOVENTURES II LLC

Pharmaceutical composition containing PRMT5 inhibitor and kras g12c inhibitor

PCT designated stageWO2025157289A1Antineoplastic agentsPharmaceutical active ingredientsViral OncogeneDisease
A pharmaceutical composition comprising a protein arginine methyltransferase 5 (PRMT5) inhibitor and a KRASG12C (Kirsten rat sarcoma viral oncogene homolog glycine-to-cysteine) inhibitor. The pharmaceutical composition can be used for treating various cancers, comprising solid tumors. The combined product can be used for treating any number of diseases associated with PRMT5 and / or KRASG12C.
Owner:SHANGHAI APEIRON THERAPEUTICS CO LTD

Method for preparing high-purity and fine-particle-size lithium sulfide based on carbon thermal reduction

The invention provides a method for preparing high-purity and fine-particle-size lithium sulfide based on carbon thermal reduction. The method comprises the following steps: weighing lithium sulfate monohydrate, an insoluble inorganic carbon source and cysteine in a set proportion to form a raw material mixture; mixing the raw material mixture with water according to a set solid-to-liquid ratio, performing ultrasonic dispersion to obtain homogeneous dispersion liquid, and enabling the dispersion liquid to pass through a nitrogen circulating spray dryer to obtain uniform and dry precursor powder; in a vacuum environment, carrying out segmented calcination to obtain a crude product lithium sulfide; and in a dry and anhydrous environment, washing the crude product lithium sulfide for multiple times by using absolute ethyl alcohol according to a set liquid-solid ratio to obtain an alcoholic solution containing lithium sulfide, and then obtaining lithium sulfide fine powder through a nitrogen circulating spray dryer. The invention solves the problems of side reaction, low purity, large product particles, uncontrollable particle size and the like of lithium sulfide prepared by a carbon thermal reduction method in the prior art.
Owner:江西云威新材料股份有限公司 +1

Fatty acid modified coronavirus antigen and application thereof

The invention discloses a fatty acid modified coronavirus antigen and application thereof, and belongs to the field of biological medicine. The fatty acid modified coronavirus antigen contains fatty acid modified N-terminal cysteine (Cys) and a coronavirus antigen, and can contain a connecting structural domain; the coronavirus antigen is a coronavirus spike protein (S protein) receptor binding domain (RBD). The fatty acid modified coronavirus S protein RBD can be self-polymerized into nanoparticles, and compared with the RBD which is not subjected to fatty acid modification, the antigen can induce faster and higher humoral immunity through injection immunity, can induce mucosal immunity and humoral immunity through respiratory tract atomization immunity, and is a candidate mucosal vaccine with potential medical value.
Owner:ACADEMY OF MILITARY MEDICAL SCIENCES

Hydrophobic and oleophobic modified epoxy resin as well as preparation method and application thereof

The invention discloses a hydrophobic and oleophobic modified epoxy resin, which is prepared from the following components in parts by mass: 2 to 5 parts of thiolactone terminated fluorinated prepolymer, 15 to 16 parts of 4, 4 '-diaminodiphenylmethane, 0.13 to 0.14 part of base catalyst, 25 to 26.5 parts of epoxy resin and the balance of tetrahydrofuran solvent, wherein the thiolactone-terminated fluorinated prepolymer is prepared from thiolactone acrylamide, fluorinated acrylate and a photoinitiator in a mass ratio of (2-3): 1: (0.07-0.09) through a free radical polymerization copolymerization chemical reaction under the induction of ultraviolet light, and the thiolactone-terminated fluorinated prepolymer is obtained; wherein thiolactone acrylamide is prepared from DL-homocysteine thiolactone hydrochloride, a NaHCO3 solution and acryloyl chloride according to the mass ratio of 1: (1.3-1.5): (1.1-1.3), the oleophobic and hydrophobic modified epoxy resin provided by the invention effectively solves the problem that an epoxy resin coating in the prior art is poor in oleophobic performance and hydrophobic performance, and the oleophobic and hydrophobic modified epoxy resin has the advantages that the oleophobic and hydrophobic properties of the epoxy resin coating are improved; therefore, the oleophobic and hydrophobic properties of the epoxy resin coating are improved.
Owner:JIANGSU SIMBA NEW MATERIAL TECH CO LTD +1

Tryptophan synthetase mutant with improved enzymatic activity and application of tryptophan synthetase mutant in production of L-cysteine

The invention belongs to the field of bioengineering, and particularly discloses a tryptophan synthetase mutant with improved enzymatic activity and application of the tryptophan synthetase mutant in production of L-cysteine. Compared with wild tryptophan synthetase from escherichia coli, the amino acid sequence of the tryptophan synthetase mutant has the advantages that a beta catalytic subunit has T69A, S143A, R219E and F280H site combined mutation. Researches show that the enzyme activity of the mutant is increased by 2.4 times compared with that of a wild type through enzyme activity determination and analysis of inducible expression and purification. The beneficial tryptophan synthetase mutant provided by the invention can efficiently biocatalyze L-serine and sodium hydrosulfide to synthesize L-cysteine, and has a better industrial application prospect.
Owner:TIANJIN INST OF IND BIOTECH CHINESE ACADEMY OF SCI

Porcine oocyte in-vitro maturation culture solution additive and application thereof

The invention provides a porcine oocyte in-vitro maturation culture solution additive and application thereof, and belongs to the field of embryo engineering, and the additive contains taurine. The additive also contains sodium pyruvate, cysteine, glucose, NaHCO3, fetal calf serum, estradiol, pregnant horse serum gonadotropin and human chorionic gonadotropin. When the porcine oocyte in-vitro maturation culture solution added with the additive is used for culturing porcine oocytes in vitro, the ROS content in the porcine oocytes can be remarkably reduced, the oxidation resistance of the porcine oocytes can be improved, and the mitochondrial distribution of the oocytes can be improved, so that the development of the oocytes can be improved; the maturation of porcine oocytes and the development of early embryos are promoted. When the technology is applied to the pig assisted reproduction technology, the success rate and quality of embryo engineering can be improved; the pig oocyte in-vitro maturation culture solution added with the additive can improve the premature embryo division rate in parthenogenetic activation of the pig oocytes.
Owner:YANGZHOU UNIV

Carbonyl reductase ChKRED20 mutant for synthesis of fused ring lactone compound and application of carbonyl reductase ChKRED20 mutant

PendingCN118995649AAchieve chiral flippingBroad substrate versatilityOxidoreductasesFermentationTyrosineCarbonyl Reductase
The invention discloses a carbonyl reductase ChKRED20 mutant for synthesis of a fused ring lactone compound and application of the carbonyl reductase ChKRED20 mutant, and belongs to the technical field of chemical biology. The carbonyl reductase ChKRED20 mutant takes an amino acid sequence of a carbonyl reductase mutant strain ChKRED20-M2 or ChKRED20-M3C1 as a starting sequence, amino acid at the 188th site and / or the 145th site is mutated, and tyrosine at the 188th site of the ChKRED20-M2 is mutated into asparagine, glycine or cysteine; or the histidine at the 145th site of the ChKRED20-M2 is mutated into the alanine, and the tyrosine at the 188th site is mutated into the serine or cysteine. According to the invention, rational design is carried out on ChKRED20 through directed evolution, the obtained mutant strain has relatively wide substrate universality, and efficient and high-selectivity asymmetric synthesis of fused ring lactone and chiral flip of fused ring lactone are realized.
Owner:SICHUAN UNIV

CMB magnetic bead kit and application thereof in cysteine modified proteomics analysis

InactiveCN119001121AConvenient for cohort studiesShorten the experimental processMaterial analysis by electric/magnetic meansBiological testingMagnetic beadEthyl group
The invention relates to the technical field of biological detection, in particular to a CMB magnetic bead kit and application thereof in cysteine modified proteomics analysis. The invention relates to a CMB magnetic bead kit. The catalyst is N, N-ethyl maleimide; a free sulfydryl selective reducing agent; a thiol-based reducing agent; a PBS buffer solution containing 4% of SDS; and a PBS buffer solution. When being used for cysteine modified proteomics analysis, the method comprises the following steps: reducing protein to be detected by using a thiol reducing agent, sealing by using NEM (New Electron Microscope), and precipitating by using an acetone method to obtain B; and redissolving B with 4% SDS-PBS, incubating with CMB magnetic beads, washing and reacting to obtain a specific protein solution, and incubating with CMB magnetic beads after the specific protein solution is used for mass spectrometry / precipitation B enzymolysis and desalination to obtain a specific redox peptide fragment for mass spectrometry. The CMB magnetic beads are directly combined with free sulfydryl, the biotin labeling step is omitted, the process is simplified, the time is shortened, large sample queue research is facilitated, and high-flux stable detection is kept.
Owner:SHANGHAI BIOPROFILE TECH CO LTD

Pertuzumab variants and evaluation thereof

The present application discloses variants of Pertuzumab. In particular, it discloses: an unpaired cysteine variant comprising Cys23 / Cys88 unpaired cysteines in one or both variable light domains of Pertuzumab, an afucosylated variant of Pertuzumab, a low-molecular-weight-species (LMWS) of Pertuzumab, and a high-molecular-weight-species (HMWS) or Pertuzumab. The application further discloses the isolated variants, compositions, pharmaceutical compositions, and articles of manufacture comprising the variants, as well as methods of making and characterizing the variants and compositions thereof.
Owner:GENENTECH INC

Respiratory syncytial virus F protein mutant and application thereof

The invention belongs to the field of biological medicine, and particularly relates to a respiratory syncytial virus F protein mutant and application thereof. The respiratory syncytial virus F protein mutant is characterized in that at least one pair of amino acid residues in an F1 subunit and / or an F2 subunit of F protein polypeptide are substituted by cysteine, and / or an F protein signal peptide part is substituted by a human immunoglobulin light chain signal peptide, and / or alanine A at the 107 site of a multi-base sequence is mutated into arginine R, lysine K at the 134 site is mutated into arginine R, and the amino acid residues in the F1 subunit and / or the F2 subunit of the F protein polypeptide are mutated into arginine. According to the invention, more neutralizing antibody epitopes can be exposed, the stable pre-fusion conformation is maintained, effective neutralizing antibody reaction and antibody binding reaction to the RSV subtypes A and B can be ensured, and the vaccine is suitable for various vaccine forms taking the RSV F protein as the antigen.
Owner:BEIJING HUANUOTAI BIOMEDICAL TECH CO LTD

Method for visible light-mediated chemical modification of polypeptide and protein based on cysteine

A method for visible light-mediated chemical modification of a polypeptide or protein based on cysteine includes the following steps: allowing a cysteine residue on a cysteine-containing oligopeptide, polypeptide, or protein to undergo a reaction with an activating reagent to generate a free radical precursor in situ; and subjecting the free radical precursor to desulfurization under photocatalytic condition, and allowing the generated free radical intermediate to undergo an addition reaction with an olefin or an alkyne, such that sulfhydryl removal and carbon-carbon bond construction are achieved to produce a chemical modification product of the polypeptide and protein. The method cleverly avoids the influence on the chiral center, and thus the chirality of the amino acid residue can be retained. The method is conducive to well avoiding the occurrence of side reactions, and thus the efficiency of the entire conversion is very high.
Owner:SHANGHAI JIAOTONG UNIV

Method for improving cordycepin synthesized by saccharomyces cerevisiae and saccharomyces cerevisiae engineering bacteria

The invention relates to the technical field of microbial genetic engineering, in particular to a method for improving cordycepin synthesized by saccharomyces cerevisiae and saccharomyces cerevisiae engineering bacteria. According to the invention, codon-optimized 2 '-carbonyl-3'-deoxyadenosine reductase gene and 3 '-adenosine monophosphate phosphohydrolase gene from cordyceps militaris are expressed by using plasmids, and then the plasmids are transformed into host cells to obtain the saccharomyces cerevisiae engineering bacteria. And inoculating a seed solution obtained by seed culture of the activated saccharomyces cerevisiae engineering bacteria into a fermentation culture medium containing a metabolic effector, and carrying out fermentation culture to synthesize cordycepin. Metabolic effectors (Cu < 2 + >, Fe < 2 + >, Mg < 2 + >, Zn < 2 + >, citric acid, cysteine, aspartic acid, glycine, VB1 and tea polyphenol) are added into a fermentation culture medium strain, and the variety and concentration of the metabolic effectors are optimized, so that the yield and synthesis efficiency of cordycepin are remarkably improved. By using the combination of the strain obtained by the invention and the optimal effector, the yield of cordycepin in a fermentation tank reaches 2.9 g / L.
Owner:NANJING TECH UNIV

Polypeptide metal chelate and application thereof in field of cosmetics

The invention relates to the field of polypeptide compositions, in particular to a polypeptide metal chelate and application thereof in the field of cosmetics, and the polypeptide metal chelate is formed by chelating a polypeptide compound and a metal ion compound. The structure of the polypeptide compound is [gamma-Glu] n-AA, n is greater than or equal to 1, and AA is selected from glycine, alanine, valine, leucine, isoleucine, methionine (methionine), proline, tryptophan, serine, tyrosine, cysteine, phenylalanine, asparagine, glutamine, threonine, asparaginic acid, glutamic acid, lysine, arginine or histidine; the polypeptide chelated zinc prepared by the invention has remarkable oil control and anti-inflammatory effects, and can be compounded with other raw materials to form cosmetics with oil control and acne removal effects.
Owner:WIJ HEALTHCARE (SHANGHAI) LTD

Method for detecting average coupling rate of antibody-coupled drug based on small molecule extinction coefficient correction and application of method

The invention provides a method for detecting the average coupling rate of an antibody-coupled drug based on small molecule extinction coefficient correction and application of the method. The method comprises the following steps: firstly, measuring the absorbance and extinction coefficient of L-cysteine-linker-toxin molecules at 280nm, and then calculating and correcting to obtain the accurate average coupling rate of the antibody coupling medicine based on the measured absorbance and extinction coefficient and liquid chromatogram conditions. According to the method, in the analysis process, through the extinction coefficient of L-cysteine-connexon-toxin molecules at the wavelength of 280 nm, the area of a liquid chromatogram peak which is collected at the wavelength of 280 nm and is reduced by ADC is corrected, so that the measured average coupling rate result is more accurate and real. Besides, the method is suitable for the antibody-coupled drug obtained in a cysteine coupling mode, and is especially suitable for the antibody-coupled drug which is strong in coupled micromolecule ultraviolet absorption and has obvious influence on a DAR result.
Owner:WUXI XDC (SHANGHAI) CO LTD

Ligand-drug conjugate, linker for conjugation, and use thereof

Provided are a ligand-drug conjugate represented by general formula Pc-(L-D)n or a pharmaceutically acceptable salt thereof, and further provided is a linker for conjugation represented by formula (L). The linker can efficiently and highly selectively perform chemical conjugation with a thiol group on cysteine, and the antibody-drug conjugate formed has good stability.
Owner:SIMCERE ZAIMING PHARMACEUTICAL CO LTD

Culture solution for recovering quality of porcine oocytes by adding uridine and application of culture solution

PendingCN119120354Aquality improvementMaturity rate rescue effectGerm cellsMetaboliteOxidative stress
The invention relates to a culture solution for recovering the quality of porcine oocytes by adding uridine. The culture solution comprises a basic culture solution and uridine, the basic culture solution contains 10% of pig follicular fluid, 0.57 mM of cysteine, 0.5 IU / mL of LH, 0.5 IU / mL of FSH, 10 ng / mL of epidermal growth factors, 1% of a double-antibody TCM 199 culture medium and the balance of water; the addition amount of uridine is 100 [mu] M of the basic culture solution. According to the method disclosed by the invention, metabolite uridine (Urd) required by a human body is used for respectively rescuing in-vitro cultured H2O2 induced oxidative stress porcine oocytes and delayed cultured aged porcine oocytes, so that the quality of the oocytes is improved.
Owner:QINGDAO AGRI UNIV

Cysteine-substituted RSV-f proteins

The present disclosure provides inter alia, an RSV-F protein comprising at least two mutations relative to SEQ ID NO: 1 or 3 within a region of the protein corresponding to positions 474-523 of SEQ ID NO: 1 or 3; wherein the at least two mutations introduce, through substitution or insertion, a pair of C residues into the region, which form a disulphide bond.
Owner:GLAXOSMITHKLINE BIOLOGICALS SA

Construction method and application of genetically engineered bacterium for efficiently producing O-acetyl-L-homoserine

The invention relates to the technical field of microbial metabolism engineering, in particular to a construction method and application of genetically engineered bacteria for efficiently producing O-acetyl-L-homoserine. The construction method specifically comprises the following steps: (1) taking a strain Escherichia coli W3110 as a chassis, and knocking out a homoserine O-succinyl transferase coding gene metA; (2) knocking out a gamma-cystathionine synthetase encoding gene metB; (3) knocking out a cysteine lyase coding gene metC; (4) carrying out weakening expression on an O-acetyl-L-homoserine thiolase coding gene metYcm from the marine cyclobacterium; (5) overexpressing a ribulose diphosphate carboxylase coding gene rbcLSse from the synechococcus elongate; (6) overexpressing a ribulose phosphate kinase coding gene prkse from the synechococcus slender; and (7) weakening the expression of the citrate synthase coding gene gltA to obtain the genetically engineered bacterium for efficiently producing the O-acetyl-L-homoserine. The strain provided by the invention is used for producing O-acetyl-L-homoserine, and has the advantages of high yield, high yield and high sugar-acid conversion rate.
Owner:ZHEJIANG UNIV OF TECH

Application of metabolite in prediction of immune reconstruction result after anti-retrovirus treatment of HIV infected person

ActiveCN119028455AEffectively predict immune reconstitution outcomesComponent separationBiostatisticsMetabolomeHiv infected
The invention discloses a metabolite composition and an application thereof in prediction of an immune reconstruction result after anti-retrovirus treatment of an HIV (Human Immunodeficiency Virus) infected person. According to the present invention, the metabolite combination and the model capable of accurately distinguishing the immune responder from the immune non-responder are firstly found, the metabolite combination and the model are respectively Glycylcycloyproline, gamma-Glutamylalanine, C16-Sphingosine-1-phosphate, didyroracil, deoxyeritadenine, creatinine, trans-S-(1-Propenyl)-L-cysteine, N6, N6, N6-Trimetyl-L-lyine and glucosamine, the content of the metabolite combination of the subject is detected so as to distinguish whether the subject can recover the optimal immunity after the subject is subjected to the anti-retrovirus treatment, and whether the subject can recover the optimal immunity after the subject is subjected to the anti-retrovirus treatment can Therefore, the treatment process of the HIV infected person is better intervened, and the treatment scheme of the HIV infected person is guided and optimized according to the treatment reaction.
Owner:THE FIFTH MEDICAL CENT OF CHINESE PLA GENERAL HOSPITAL

Method for synthesizing S-sulfo-L-cysteine through multi-enzyme cascade catalysis

The invention relates to the technical field of biology, in particular to a method for synthesizing S-sulfo-L-cysteine through multi-enzyme cascade catalysis. The invention provides a new route for biosynthesis of S-sulfo-L-cysteine, and a test result shows that serine, AMP, sodium hexametaphosphate and sodium thiosulfate are used as substrates, and the S-sulfo-L-cysteine is synthesized by a one-step method. A crude enzyme liquid which contains serine kinase, polyphosphoric acid-AMP phosphotransferase and phosphoserine dependent type S-sulfo-L-cysteine synthetase in which the background of tryptophanase and glutaredoxin cells is knocked out is used for synthesizing the S-sulfo-L-cysteine, the steps are simple, the product yield is high, the cost is low, and the method has a relatively strong industrial application prospect.
Owner:SHENZHEN READLINE BIOTECH CO LTD

The invention relates to 3apos; -adenosine monophosphate-5apos; phosphoryl sulfate synthetase mutant and application thereof

The invention discloses a 3 '-phosphoadenosine-5'-phosphoryl sulfate synthetase mutant and an application of the 3 '-phosphoadenosine-5'-phosphoryl sulfate synthetase mutant. Compared with a wild enzyme amino acid sequence as shown in SEQ ID NO.1, the amino acid sequence of the 3 '-adenosine-5'-phosphoryl sulfate synthetase mutant has one or two mutations in the 101 site, the 207 site and the 560 site; preferably, phenylalanine at the 101 site is mutated into tryptophan; cysteine at the 207th site is mutated into glycine; phenylalanine at the 560th site is mutated into tryptophan. The invention also provides a synthesis method and application of the 3 '-adenosine-5'-phosphoryl sulfuric acid. The APS intermediate product inhibition effect of hPAPSS1 is relieved through a point mutation technology, the substrate affinity of hPAPSS1 to ATP is improved, and a mutant enzyme with a high PAPS conversion rate is obtained; and the bifunctional enzyme hPAPSS1 is synthesized by heterologous expression of PAPS in escherichia coli, so that the acquisition of the enzyme is simplified, and the synthesis efficiency of PAPS is improved.
Owner:ZHEJIANG FORESTRY UNIVERSITY

Molecular marker related to leukoderma resistance on corn chromosome 4 and application of molecular marker

The invention belongs to the technical field of molecular marker assisted breeding, particularly relates to a molecular marker related to white spot resistance on a corn chromosome 4 and application, and particularly provides the molecular marker related to the corn white spot resistance, the gene of the molecular marker is a Zm00001eb168510 gene and / or a sequence as shown in SEQ ID NO: 1, the CDs sequence of the Zm00001eb168510 gene is as shown in SEQ ID NO: 2, and the CDs sequence of the Zm00001eb168510 gene is as shown in SEQ ID NO: 1. According to the invention, through many years of multi-site experiments, the white spot resistance QTL qMWS4-4 interval and the resistance SNP: 4-14146725 and the associated gene Zm00001eb168510 thereof are jointly localized on the corn chromosome 4, the SNP locus can be localized in different environments through QTL linkage analysis and GWAS association analysis, and 15.14% of phenotypic variation can be explained; the associated candidate functional gene mainly encodes cysteine protease superfamily protein, and a cysteine protease large family contains deubiquitination enzyme which plays an important role in plant development and stress response.
Owner:FOOD CROPS RES INST YUNNAN ACAD OF AGRI SCI

Preparation method of modified thiol curing agent and application of modified thiol curing agent in epoxy resin

The invention discloses a preparation method of a modified thiol curing agent and application of the modified thiol curing agent in epoxy resin, indole-5-formaldehyde and trimesoyl chloride are subjected to amidation reaction, then the amidation reaction and DL-cysteine are subjected to Schiff base condensation and reduction reaction, finally the amidation reaction and methoxypolyethylene glycol are subjected to esterification reaction, and the novel modified thiol curing agent is obtained. The curing agent contains a plurality of sulfydryl groups, a plurality of imino groups and a large amount of reactive hydrogen, can form a stable curing cross-linked network with epoxy resin, and is low in curing system temperature and high in curing speed. And the modified thiol curing agent contains a plurality of flexible polyether molecular chains, has a very good toughening effect on the epoxy resin, remarkably improves the elongation at break of the epoxy resin, and also has good tensile strength and heat resistance.
Owner:GUANGZHOU FEISI SYNTHETIC MATERIAL CO LTD

Fine mist preparation method of Janus polyester fabric with one-way moisture conduction and antibacterial functions

The invention belongs to the field of new textile materials, and discloses a mist preparation method of a Janus polyester fabric with one-way moisture conduction and antibacterial functions, which comprises the following steps: step 1, spraying and grafting an aminopropyltriethoxysilane solution to the surface of one side of the polyester fabric, washing and drying to obtain an aminated / polyester fabric; step 2, spraying a mixed aqueous solution of copper acetate and cysteine to the surface of the same side of the polyester fabric, baking, and repeating the spraying-baking operation for three times to obtain the Janus polyester fabric with the one-way moisture conduction and antibacterial functions. The problems that an existing preparation method is complex and high in energy consumption, and the prepared polyester fabric is single in function, large in skin irritation, poor in sanitary safety and the like are solved, and meanwhile the original wearing properties such as tensile strength and flexibility of the polyester fabric can be reserved.
Owner:ZHEJIANG SCI-TECH UNIV +1

Preparation method for constructing phage display cyclopeptide library based on phthalic dicarboxaldehyde

The invention relates to the technical field of polypeptide cyclization methods, in particular to a preparation method for constructing a phage display cyclopeptide library based on phthalic dicarboxaldehyde, which comprises the following steps: carrying out click chemical reaction on phthalic dicarboxaldehyde (OPA) and lysine and cysteine in an unprotected peptide sequence under a neutral or alkaline condition to form cyclopeptide; constructing a phage cyclic peptide library on the basis of the reaction property that the OPA molecule is efficiently biocompatible with sulfydryl and amino groups; a polypeptide library containing cysteine and lysine is displayed on a bacteriophage, the polypeptide library is cyclized by utilizing OPA (o-phthalaldehyde), and a cyclic peptide ligand with specific binding is screened out aiming at a target protein. In the strategy of performing polypeptide cyclization by using o-phthalaldehyde, it is found that o-phthalaldehyde has good reaction activity with sequence peptide containing cysteine and lysine, reaction conditions are simple and mild, and the o-phthalaldehyde has good biocompatibility. The reaction system does not need organic solvents or metal catalysts and is suitable for biological systems.
Owner:HUBEI PEPTIDE BIOTECHNOLOGY CO LTD

Anti-oxidation gel for wound healing as well as preparation method and application of anti-oxidation gel

InactiveCN119113195AImprove tissue adhesionreduce oxidative stressBandagesAntioxidant capacityWound healing
The invention relates to antioxidant gel for wound healing as well as a preparation method and application of the antioxidant gel. The antioxidant gel is prepared from the following components in parts by mass: 0.01 to 20 parts of hyaluronic acid, 0.01 to 20 parts of cysteine and 1 to 50 parts of polyethylene glycol carboxyl activated ester. The cysteine modified hyaluronic acid and the polyethylene glycol carboxyl activated ester are cross-linked to form a hydrogel network, the tissue adhesion capacity of the hyaluronic acid gel is remarkably improved, the antioxidant capacity and the anti-inflammatory capacity are further improved, and the hydrogel material is simple in component, good in biocompatibility, stable in cross-linked network and biosafe.
Owner:SUZHOU XIUBAO BIOTECHNOLOGY CO LTD

A natural composite flavor enhancer and its preparation method

The present invention discloses a natural composite flavor enhancer and a preparation method thereof, comprising the following steps: using an ultramicro grinder to crush rice wine lees and wheat gluten powder to obtain ultramicro wheat gluten powder and ultramicro rice wine lees powder; taking the ultramicro wheat gluten powder, sterile water, and protease, mixing them evenly, carrying out enzymatic hydrolysis, inactivating the enzyme after the reaction ends, filtering, and taking the filtrate, namely the wheat gluten powder enzymatic hydrolysate, for standby; taking the wheat gluten powder enzymatic hydrolysate, ultramicro rice wine lees powder, and sterile water, mixing them evenly, carrying out enzymatic hydrolysis, inactivating the enzyme after the reaction ends, filtering, and taking the filtrate, namely the composite enzymatic hydrolysate, for standby; taking the composite enzymatic hydrolysate, cysteine, xylose, glucose, granulated sugar, and salt, mixing them and carrying out a thermal reaction to obtain a reaction solution; and preparing the natural flavor enhancer by spray drying. The present invention utilizes the natural enzyme system in rice wine lees to synergistically enzymatically hydrolyze wheat gluten powder to promote the release of umami amino acids, and further strengthens the umami by using thermal reaction technology.
Owner:TIANJIN CHUNFA BIO TECH GRP

Eye spot brassica rapa adult feed and preparation method thereof

The invention discloses a brassica rapa imago feed and a preparation method thereof, and belongs to the technical field of insect breeding. The Eye spot Brassica rapa adult feed comprises 11 to 15 parts of casein, 1 to 3 parts of Webster salt, 4 to 6 parts of cane sugar, 9 to 12 parts of cellulose powder, 0.2 to 0.4 part of L-cysteine, 0.2 to 0.3 part of choline chloride, 0.08 to 0.1 part of inositol, 0.325 to 0.4 part of composite vitamin, 2 to 3 parts of a nutritional ingredient ethanol solution, 12 to 14 parts of a nutritional ingredient aqueous solution, 1 to 2 parts of honey, 2 to 3 parts of agar powder, 0.03 to 0.04 part of cholesterol, 33 to 67 parts of apple jam, 0.3 to 4 parts of royal jelly and 80 to 120 parts of water. In addition, the invention also provides a preparation method of the feed for the Eye spot Brassica rapa imagoes. The feed for the Eye spot Brassica rapa adults can prolong the life of the adults and improve the egg laying amount at the same time.
Owner:ZUNYI MEDICAL UNIVERSITY

Pharmaceutical composition for promoting angiogenesis and tissue regeneration and application thereof

The invention discloses a pharmaceutical composition for promoting angiogenesis and tissue regeneration and application thereof. The pharmaceutical composition of the present invention comprises an acidic secretory protein rich in cysteine, a disaccharide chain proteoglycan, and an XV-type collagen alpha1 chain. The biological material system loaded with the three types of proteins can promote angiogenesis, and can improve the tissue regeneration efficiency of bone, cartilage and skin defect areas.
Owner:PEKING UNIV SCHOOL OF STOMATOLOGY